• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Wearable sensor device helps visually impaired to sense their environment

Bioengineer by Bioengineer
January 10, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

VTT Technical Research Centre of Finland has developed a wearable assistive device for the visually impaired, which enables them to sense their environment and move around more safely. The device, which is worn like a heart rate monitor, has been clinically tested.

The device functions on the basis of a radar system developed by VTT.

"The novel aspect lies in wearable sensor device which functions based on radio waves, so that the signal passes through clothing. This means that it can be worn discreetly under a coat, for example," says Tero Kiuru, a Senior Scientist at VTT.

The radar conveys information to the user in the form of vibrations or voice feedback. It senses most obstacles in the user's surroundings, although difficulties remain in sensing objects such as thin branches and bushes.

The radar has already been clinically tested in device trials approved by the National Supervisory Authority for Welfare and Health (Valvira), in which VTT's partners were Kuopio University Hospital and the Finnish Federation of the Visually Impaired (FFVI). The test group included a total of 25 visually impaired people, of whom 14 were blind, 7 partially sighted and 4 were deaf-blind.

"A clear majority of the testers felt that the radar improved their ability to perceive their environment and increased their self-confidence when moving around," says Kiuru.

A total of 92% of the trial users felt that the device helped them to perceive their surroundings, 80% felt that their trust in their ability to move around independently had increased and 32% would immediately start using the test device in its current form.

On the other hand, they were not satisfied with distance control and vibration-based feedback.

The research will continue with selected test users and the device will be further developed.

A global market is believed to exist for the radar, since there are around 300 million visually impaired people in the world.

###

http://www.guidesense.com

Further information:

VTT
Tero Kiuru, Senior Scientist
Tel. +358 40 176 8566
[email protected]

Further information on VTT:

Olli Ernvall
Senior Vice President, Communications
358 20 722 6747
[email protected]
http://www.vtt.fi

VTT Technical Research Centre of Finland Ltd is the leading research and technology company in the Nordic countries. We use our research and knowledge to provide expert services for our domestic and international customers and partners, and for both private and public sectors. We use 4,000,000 hours of brainpower a year to develop new technological solutions. VTT in social media: Twitter @VTTFinland, Facebook, LinkedIn, YouTube, Instagram and Periscope.

Media Contact

Tero Kiuru
[email protected]
358-401-768-566
@VTTFinland

http://www.vtt.fi/?lang=en

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Harnessing T Cell Potential: Oxford Researchers Chart the Future of Cancer Immunotherapy

Harnessing T Cell Potential: Oxford Researchers Chart the Future of Cancer Immunotherapy

October 24, 2025

Low-Dose Dienogest: 48 Weeks of Endometriosis Relief

October 24, 2025

Democratizing Protein Language Models: Training, Sharing, Collaborating

October 24, 2025

ARHGAP11A: Pan-Cancer DNA Damage Biomarker Revealed

October 24, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1279 shares
    Share 511 Tweet 319
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    308 shares
    Share 123 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    184 shares
    Share 74 Tweet 46
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    133 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Harnessing T Cell Potential: Oxford Researchers Chart the Future of Cancer Immunotherapy

Low-Dose Dienogest: 48 Weeks of Endometriosis Relief

Democratizing Protein Language Models: Training, Sharing, Collaborating

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.